Cargando…

Pharmacological Treatment of Acute Coronary Syndromes

This book updates clinicians on the most recent data regarding the medical management of patients of acute coronary syndrome (ACS), providing useful information and expert opinion on the large trials, international guidelines, and clinical practice. It reinforces the need for rapid intervention with...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Avanzas, Pablo (Editor ), Clemmensen, Peter (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Springer London : Imprint: Springer, 2014.
Edición:1st ed. 2014.
Colección:Current Cardiovascular Therapy,
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4471-5424-2
003 DE-He213
005 20220322150345.0
007 cr nn 008mamaa
008 131004s2014 xxk| s |||| 0|eng d
020 |a 9781447154242  |9 978-1-4471-5424-2 
024 7 |a 10.1007/978-1-4471-5424-2  |2 doi 
050 4 |a RC666-701.2 
072 7 |a MJD  |2 bicssc 
072 7 |a MED010000  |2 bisacsh 
072 7 |a MJD  |2 thema 
082 0 4 |a 616.12  |2 23 
245 1 0 |a Pharmacological Treatment of Acute Coronary Syndromes  |h [electronic resource] /  |c edited by Pablo Avanzas, Peter Clemmensen. 
250 |a 1st ed. 2014. 
264 1 |a London :  |b Springer London :  |b Imprint: Springer,  |c 2014. 
300 |a XVI, 245 p. 24 illus., 12 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Cardiovascular Therapy,  |x 2946-8191 
505 0 |a Foreword -- Preface -- Anti-ischemic Therapy -- Antiaggregant Therapy: New potent P2Y12 inhibitors -- Anticoagulation Therapy: Heparins and Factor Xa inhibitors -- Secondary prevention in ACS The role of novel oral anticoagulants -- American vs European guidelines -- Critical appraisal -- Triple therapy: Risky but sometimes necessary -- Management of bleeding complications. 
520 |a This book updates clinicians on the most recent data regarding the medical management of patients of acute coronary syndrome (ACS), providing useful information and expert opinion on the large trials, international guidelines, and clinical practice. It reinforces the need for rapid intervention with pharmacologic therapies to treat and prevent coronary thromboembolism, and to prepare the patient for revascularization procedures, especially percutaneous coronary intervention. Pharmacological Treatment of Acute Coronary Syndromes describes conventional treatment - including anti-ischemic, antiplatelet and anticoagulant therapy - and discusses the clinical use of newer treatment options: the potent new P2Y12 platelet receptor inhibitors with the recently recommended ticagrelor and prasugrel, and new oral anticoagulant agents showing promise for acute management and secondary prevention in ACS. Triple therapy, while not initiated in the acute setting, may impact on future surgical and medical emergencies and their management. Also covered are the various recommendations for each of the antiplatelet and anticoagulant agents in terms of patient selection, pretreatment and timing of therapy, making this book an essential read for a wide range of health professionals. 
650 0 |a Cardiology. 
650 0 |a Pharmacy. 
650 0 |a Therapeutics. 
650 1 4 |a Cardiology. 
650 2 4 |a Pharmacy. 
650 2 4 |a Therapeutics. 
700 1 |a Avanzas, Pablo.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Clemmensen, Peter.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781447154259 
776 0 8 |i Printed edition:  |z 9781447154235 
830 0 |a Current Cardiovascular Therapy,  |x 2946-8191 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4471-5424-2  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)